Get the Stockscreener App
334.58
0.85%
2.81
After Hours:
334.58
Bio Rad Laboratories Inc stock is traded at $334.58, with a volume of 154.47K.
It is up +0.85% in the last 24 hours and down -0.81% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$331.77
Open:
$330.9
24h Volume:
154.47K
Relative Volume:
0.54
Market Cap:
$9.29B
Revenue:
$2.56B
Net Income/Loss:
$-1.33B
P/E Ratio:
-57.19
EPS:
-5.85
Net Cash Flow:
$177.42M
1W Performance:
+2.44%
1M Performance:
-0.81%
6M Performance:
-3.26%
1Y Performance:
-6.66%
1-Day Range:
$328.64
$335.48
1-Week Range:
$315.31
$337.00
52-Week Range:
$261.59
$366.30
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector? - MSN
Bio-Rad Laboratories Stock: Is BIO Underperforming The Healthcare Sector? - Barchart
Cell Sorting Market Global Industry, Share, In-Depth - openPR
Escherichia Coli Strain Market Generated Opportunities, - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Toronto Dominion Bank - MarketBeat
Gene Expression Analysis MarketBusiness Opportunities with - openPR
Trend Tracker for (BIO) - Stock Traders Daily
Scientech Research LLC Invests $1.19 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Wall Street SWOT: Bio-Rad stock faces headwinds but maintains long-term appeal - Investing.com
Global MicroRNA Market Size Projected to Reach USD 7.7 Billion by 2032, with 21.1% CAGR – SNS Insider - GlobeNewswire Inc.
3,785 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Bought by Caxton Associates LP - MarketBeat
Cell Sorting Market 2024 Sales Industry and Forecast till 2032 Becton, Dickinson and Company, Beckman Coulter, Bio-Rad Laboratories – Cauverynews - Cauverynews
In Vitro Diagnostics Ivd Market Experiencing Global Surge from - openPR
Research Antibodies Market Comprehensive Study Report - openPR
DNA Extraction Kits Market Explored in New Research Report - openPR
S&P 500 Shake-Up: New Entrants Driving Market Momentum - Benzinga
DNA Sequencing Market Growth with Trends, Analysis by Regions, - openPR
Blood Screening Market Types, Applications, Share, Growth - openPR
Blotting Systems Market Competition & Segment Analysis – Advansta Inc., Bio-Rad Laboratories, Bio-Techne Corporation, Cell Signaling Technology, Danaher Corporation – Cauverynews - Cauverynews
Ariel Investments LLC Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Autoimmune Diagnostics Market to Reflect a Holistic Expansion - openPR
Molecular Quality Controls Market Research Covers Top Players as SeraCare Life Sciences, ZeptoMetrix Corporation, Bio-Rad Laboratories, Microbiologics Inc – Cauverynews - Cauverynews
Biopharma Buffer Market to Witness Exponential Growth from 2023 - openPR
Oncology Companion Diagnostic Market 2024 Latest Future Scope - openPR
Microplate Incubators Market: Latest Key Trends And Opportunity Analysis | Labocon, Labnet, BMG LABTECH, Bio-Rad Laboratories – Cauverynews - Cauverynews
Microplate Absorbance Reader Market Size, Share, Price, Trend And Forecast To 2032 | Bio-Rad Laboratories, BioTek Instruments, Inc., PerkinElmer Inc. – Cauverynews - Cauverynews
Protein Detection And Quantification Market Expecting Huge - openPR
Applications of Cell Cytometry Market: From Diagnostics to Drug - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Hsbc Holdings PLC Acquires 6,450 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Protein Characterization Instrument Market FAQs - Talented India
Bio-Rad Laboratories: Overvalued Given Current Growth Prospects (NYSE:BIO) - Seeking Alpha
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat
Rhumbline Advisers Makes New $1 Million Investment in Beyond, Inc. (NYSE:BYON) - MarketBeat
Sei Investments Co. Has $65.59 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Dimensional Fund Advisors LP Has $135.08 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Dimensional Fund Advisors LP Has $135.08 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Zacks Research Research Analysts Decrease Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Beyond (NYSE:BYON) Shares Up 3.2% - Defense World
Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.3% - MarketBeat
Comprehensive Study of HIV Diagnostics Market Projected - openPR
Rapid PCR Test Kit Market Trending Research Report | Abbott Laboratories, PerkinElmer, Inc, Bio-Rad Laboratories - Cauverynews
Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat
Helicobacter Pylori Antigen Test Market Leading Vendors – Abbott Laboratories, Bio-Rad Laboratories, DiaSorin, Dynex Technologies – Mkural - Mkural
Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production - MSN
First Eagle Investment Management LLC Buys 634,311 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September. - Barron's
Bio-Rad Laboratories, Inc. (NYSE:BIO) Expected to Post Q3 2024 Earnings of $2.13 Per Share - MarketBeat
Monkeypox (MPOX) Diagnostics Global Markets 2024-2028: New Strains Threaten New Outbreaks - GlobeNewswire Inc.
Spectrometry Market Expected to Expand at a Steady 2024-2031 | - openPR
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):